A group of researchers led by Gilbert Chu, professor of medicine and of biochemistry, have developed a prototype of a portable device that people could use to test ammonia levels at home.

Researchers at the School of Medicine have discovered that cells infected by viruses or bacteria send out a “don’t eat me” signal to avoid attack by the body’s immune system. Irving Weissman, the Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research and director of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine, shares co-senior authorship of the paper.

People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19. Catherine Blish, associate professor of medicine, and medical student Samuel Rubin are mentioned in this article.

Two recent Stanford-led studies show the value of tweaking vaccines to enlist the entire immune system — not just part of it — in preventing HIV infection. Bali Pulendran, the Violetta L. Horton Professor and professor of pathology and of microbiology and immunology, led the study.

Stanford scientists have built a detailed picture of the biological clock of pregnancy, tracking thousands of metabolic markers throughout gestation. Michael Snyder, the Stanford W. Ascherman, MD, FACS, Professor and chair of genetics, is co-senior author of the study and is quoted in this post.

Protein levels in people’s blood can predict their age, a Stanford study has found. The study also found that aging isn’t a smoothly continuous process.

CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.

Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.

“Never could I have imagined the work I am doing now – not even ten years ago.” - Devavani Chatterjea, PhD, MPH

Researchers at Stanford and UCSF slowed the spread of a type of nonsmall cell lung cancer in mice by neutralizing a single protein that would otherwise set off a chain reaction, causing runaway tumor growth.

Andra Blomkalns, Gerald Grant, David Kingsley and Crystal Mackall have been appointed to endowed professorships.

Michal Caspi Tal, PhD Postdoctoral Research Fellow, Stem Cell Biology and Regenerative Medicine, Stanford University, leads the infectious disease team within Irving Weissman’s lab at Stanford University receives the 2018 Emerging Leader Award ($100,000 grant).

David Schneider, whose research focuses on resilience to infection and developing mathematical models to predict recovery and well-being, succeeds Peter Sarnow in post.

A common signaling pathway unites diverse fibrotic diseases in humans, Stanford researchers have found. An antibody called anti-CD47, which is being tested as an anti-cancer agent, reverses fibrosis in mice.

To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.

The researchers will be given funding by the Chan Zuckerberg Biohub to develop tools and technologies that support the organization’s goal of curing, preventing or managing every disease.

Stanford researchers and their collaborators have found a way to tell whether patients with systemic sclerosis were improving during drug treatment a year before a standard clinical test could.

The California Institute for Regenerative Medicine awarded Samuel Strober, MD, $6.6 million to study a “deceptively simple” way to help kidney transplant recipients tolerate their new organ.

The medical school professors were awarded the grants as part of a large-scale National Institutes of Health program to study the biology of how physical activity improves health.

Stanford faculty members in medicine and in Earth science have been elected fellows of the American Association for the Advancement of Science.

The FDA is funding a collaboration between Stanford and UCSF to improve the regulatory infrastructure that helps to shape modern biomedical research.